Overview

The Effect of a Preoperative Single-dose Methylprednisolone on the Postoperative Rehabilitation After Abdominal Hysterectomy

Status:
Completed
Trial end date:
2011-10-01
Target enrollment:
0
Participant gender:
Female
Summary
The purpose of this study is to evaluate the effect of 125 mg methylprednisolone, given intravenously 60-90 minutes before abdominal surgery,on the postoperative rehabilitation after abdominal hysterectomy.Sodium Chloride is the placebo. The following parameters are registered: 1. Pain 3, 6 and 24 hours postoperatively and 2-7 days after surgery. 2. The postoperative use of additional analgesics. 3. Inflammatory parameters before and after surgery. 4. Time until mobilization. 5. Time until discharge.
Phase:
Phase 4
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Holbaek Sygehus
Treatments:
Methylprednisolone
Methylprednisolone Acetate
Methylprednisolone Hemisuccinate
Prednisolone
Prednisolone acetate
Prednisolone hemisuccinate
Prednisolone phosphate
Criteria
Inclusion Criteria:

- Patients having an abdominal hysterectomy on a benign indication.

- Patients who speak and understand Danish.

- Patients who can give informed consent.

Exclusion Criteria:

- Diabetics

- Regular use of glucocorticoids, opioids or tranquilizers

- Regular treatment with immunosuppressives

- Alcohol or drug abuse

- Morphine intolerance

- Age under 18

- Chronic pain disease eg fibromyalgia, rheumatoid arthritis

- Malign indication for hysterectomy

- BMI over 35

- Decreased kidney function

- ASA III or IV